We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » GLAXOSMITHKLINE BEGINS TESTING NEW TECHNOLOGY TO PROTECT PATIENTS AGAINST COUNTERFEIT MEDICINE
GLAXOSMITHKLINE BEGINS TESTING NEW TECHNOLOGY TO PROTECT PATIENTS AGAINST COUNTERFEIT MEDICINE
March 23, 2006
GlaxoSmithKline has begun distributing a medicine tagged with radio frequency identification (RFID) technology as part of a pilot project to help protect patient safety. Finanzen.net